Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New power wheelchair rule is official

This article was originally published in The Gray Sheet

Executive Summary

As of April 1, beneficiaries must meet face-to-face with a healthcare practitioner to receive a prescription for a power mobility device. The rule replaces CMS' former "bed-or-chair confined" criterion. According to CMS, the practitioner must also submit documentation from the beneficiary's medical history as evidence of the need for the device. The final rule differs from the interim final rule in that it gives a practitioner 45 days, rather than 30 days, to submit documentation to an equipment supplier after conducting the interview. During a September forum on the CMS decision, suppliers complained that the new prescription method was more complicated than the system it replaces (1"The Gray Sheet" Sept. 19, 2005, p. 9). The final rule also provides an add-on payment to practitioners for the work involved in compiling and transmitting the required documentation to the DME supplier...

As of April 1, beneficiaries must meet face-to-face with a healthcare practitioner to receive a prescription for a power mobility device. The rule replaces CMS' former "bed-or-chair confined" criterion. According to CMS, the practitioner must also submit documentation from the beneficiary's medical history as evidence of the need for the device. The final rule differs from the interim final rule in that it gives a practitioner 45 days, rather than 30 days, to submit documentation to an equipment supplier after conducting the interview. During a September forum on the CMS decision, suppliers complained that the new prescription method was more complicated than the system it replaces (1 (Also see "Power Wheelchair Suppliers Spar With CMS Over New Regs" - Medtech Insight, 19 Sep, 2005.), p. 9). The final rule also provides an add-on payment to practitioners for the work involved in compiling and transmitting the required documentation to the DME supplier....

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023396

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel